LALPATHLABHealthcare Service Provider
Dr Lal PathLabs Ltd — Profit & Loss Statement
₹1312.10
-0.17%
Dr Lal PathLabs Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | 3.08 Cr | 2.94 Cr | -0.99 Cr | 0.00 |
| Tax Rate For Calcs | 0.21 | 0.28 | 0.30 | 0.26 |
| Normalized EBITDA | 774.49 Cr | 668.02 Cr | 534.87 Cr | 613.20 Cr |
| Total Unusual Items | 14.54 Cr | 10.39 Cr | -3.31 Cr | 3.75 Cr |
| Total Unusual Items Excluding Goodwill | 14.54 Cr | 10.39 Cr | -3.31 Cr | 3.75 Cr |
| Net Income From Continuing Operation Net Minority Interest | 487.14 Cr | 357.74 Cr | 238.85 Cr | 344.80 Cr |
| Reconciled Depreciation | 141.92 Cr | 143.60 Cr | 150.19 Cr | 108.10 Cr |
| Reconciled Cost Of Revenue | 823.12 Cr | 764.43 Cr | 729.19 Cr | 502.30 Cr |
| EBITDA | 789.03 Cr | 678.41 Cr | 531.55 Cr | 613.20 Cr |
| EBIT | 647.10 Cr | 534.81 Cr | 381.36 Cr | 505.10 Cr |
| Net Interest Income | 44.15 Cr | 26.07 Cr | -4.36 Cr | -30.20 Cr |
| Interest Expense | 22.30 Cr | 29.36 Cr | 37.53 Cr | 30.20 Cr |
| Interest Income | 66.46 Cr | 55.43 Cr | 33.18 Cr | 47.26 Cr |
| Normalized Income | 475.68 Cr | 350.29 Cr | 241.17 Cr | 344.80 Cr |
| Net Income From Continuing And Discontinued Operation | 487.14 Cr | 357.74 Cr | 238.85 Cr | 344.80 Cr |
| Total Expenses | 1.90K Cr | 1.76K Cr | 1.67K Cr | 1.35K Cr |
| Rent Expense Supplemental | 30.60 Cr | 27.17 Cr | 24.90 Cr | 26.06 Cr |
| Diluted Average Shares | 8.34 Cr | 8.32 Cr | 8.31 Cr | 8.29 Cr |
| Basic Average Shares | 8.33 Cr | 8.31 Cr | 8.29 Cr | 8.27 Cr |
| Diluted EPS | 58.40 | 42.98 | 28.74 | 41.57 |
| Basic EPS | 58.48 | 43.05 | 28.82 | 41.70 |
| Diluted NI Availto Com Stockholders | 487.14 Cr | 357.74 Cr | 238.85 Cr | 344.80 Cr |
| Net Income Common Stockholders | 487.14 Cr | 357.74 Cr | 238.85 Cr | 344.80 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 487.14 Cr | 357.74 Cr | 238.85 Cr | 344.80 Cr |
| Minority Interests | -5.11 Cr | -4.56 Cr | -2.23 Cr | -5.50 Cr |
| Net Income Including Noncontrolling Interests | 492.25 Cr | 362.29 Cr | 241.08 Cr | 350.30 Cr |
| Net Income Continuous Operations | 492.25 Cr | 362.29 Cr | 241.08 Cr | 350.30 Cr |
| Tax Provision | 132.55 Cr | 143.16 Cr | 102.75 Cr | 124.60 Cr |
| Pretax Income | 624.80 Cr | 505.45 Cr | 343.83 Cr | 474.90 Cr |
| Other Non Operating Income Expenses | 5.66 Cr | 2.12 Cr | 0.03 Cr | -232.00 Cr |
| Special Income Charges | -6.39 Cr | -70000.00 | -9.73 Cr | 0.59 Cr |
| Other Special Charges | 1.82 Cr | -0.71 Cr | -1.50 Cr | 0.10 Cr |
| Write Off | 4.57 Cr | 0.72 Cr | 11.24 Cr | -0.70 Cr |
| Net Non Operating Interest Income Expense | 44.15 Cr | 26.07 Cr | -4.36 Cr | -30.20 Cr |
| Interest Expense Non Operating | 22.30 Cr | 29.36 Cr | 37.53 Cr | 30.20 Cr |
| Interest Income Non Operating | 66.46 Cr | 55.43 Cr | 33.18 Cr | 47.26 Cr |
| Operating Income | 560.44 Cr | 466.87 Cr | 351.46 Cr | 737.10 Cr |
| Operating Expense | 1.08K Cr | 995.20 Cr | 935.99 Cr | 848.00 Cr |
| Other Operating Expenses | 209.97 Cr | 204.38 Cr | 213.60 Cr | 375.00 Cr |
| Depreciation And Amortization In Income Statement | 141.92 Cr | 143.60 Cr | 150.19 Cr | 108.10 Cr |
| Amortization | 60.69 Cr | 60.15 Cr | 60.41 Cr | 30.14 Cr |
| Depreciation Income Statement | 81.23 Cr | 83.45 Cr | 89.78 Cr | 108.10 Cr |
| Selling General And Administration | 212.98 Cr | 195.62 Cr | 171.02 Cr | 167.79 Cr |
| Selling And Marketing Expense | 77.84 Cr | 73.35 Cr | 50.78 Cr | 36.76 Cr |
| General And Administrative Expense | 135.13 Cr | 122.27 Cr | 120.24 Cr | 131.02 Cr |
| Rent And Landing Fees | 30.60 Cr | 27.17 Cr | 24.90 Cr | 26.06 Cr |
| Gross Profit | 1.64K Cr | 1.46K Cr | 1.29K Cr | 1.59K Cr |
| Cost Of Revenue | 823.12 Cr | 764.43 Cr | 729.19 Cr | 502.30 Cr |
| Total Revenue | 2.46K Cr | 2.23K Cr | 2.02K Cr | 2.09K Cr |
| Operating Revenue | 2.46K Cr | 2.23K Cr | 2.02K Cr | 2.09K Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Dr Lal PathLabs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.